{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:19:11Z","timestamp":1790713151062,"version":"4.1.0"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Magnetic Resonance Image-guided High Intensity Focused Ultrasound (MR-HIFU) is a non-invasive treatment option for palliative patients with painful bone metastases. Early evidence suggests that MR-HIFU is associated with similar overall treatment response, but more rapid pain palliation compared to external beam radiotherapy (EBRT). This modelling study aimed to assess the cost-effectiveness of MR-HIFU as an alternative treatment option for painful bone metastases from the perspective of the German Statutory Health Insurance (SHI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>A microsimulation model with lifelong time horizon and one-month cycle length was developed. To calculate the incremental cost-effectiveness ratio (ICER), strategy A (MR-HIFU as first-line treatment or as retreatment option in case of persistent pain or only partial pain relief after EBRT) was compared to strategy B (EBRT alone) for patients with bone metastases due to breast, prostate, or lung cancer. Input parameters used for the model were extracted from the literature. Results were expressed as EUR per quality-adjusted life years (QALYs) and EUR per pain response (i.e., months spent with complete or partial pain response). Deterministic and probabilistic sensitivity analyses (PSA) were performed to test the robustness of results, and a value of information analysis was conducted.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Compared to strategy B, strategy A resulted in additional costs (EUR 399) and benefits (0.02 QALYs and 0.95 months with pain response). In the base case, the resulting ICERs (strategy A vs. strategy B) are EUR 19,845\/QALY and EUR 421 per pain response. Offering all patients MR-HIFU as first-line treatment would increase the ICER by 50% (31,048 EUR\/QALY). PSA showed that at a (hypothetical) willingness to pay of EUR 20,000\/QALY, the probability of MR-HIFU being cost-effective was 52%. The expected value of perfect information (EVPI) for the benefit population in Germany is approximately EUR 190 Mio.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Although there is considerable uncertainty, the results demonstrate that introducing MR-HIFU as a treatment alternative for painful bone metastases might be cost-effective for the German SHI. The high EVPI indicate that further studies to reduce uncertainty would be worthwhile.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2022.987546","type":"journal-article","created":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T01:19:26Z","timestamp":1663895966000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Early economic modeling of magnetic resonance image-guided high intensity focused ultrasound compared to radiotherapy for pain palliation of bone metastases"],"prefix":"10.3389","volume":"12","author":[{"given":"Julia","family":"Sim\u00f5es Corr\u00eaa Galendi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sin Yuin","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Gr\u00fcll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grischa","family":"Bratke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Akuamoa-Boateng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Baues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"Bos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena M.","family":"Verkooijen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arim","family":"Shukri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Stock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,23]]},"reference":[{"key":"B1","first-page":"65","article-title":"Pathogenesis and pharmacological treatment of bone pain in skeletal metastases","volume":"45","author":"Ripamonti","year":"2001","journal-title":"Q J Nucl Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60236-5","article-title":"Treatment of cancer pain","volume":"377","author":"Portenoy","year":"2011","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2010.10.002","article-title":"Implications of bone metastases and the benefits of bone-targeted therapy","author":"Lipton","year":"2010","journal-title":"Semin Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70556-4","article-title":"Single versus multiple fractions of repeat radiation for painful bone metastases: a randomised, controlled, non-inferiority trial","volume":"15","author":"Chow","year":"2014","journal-title":"Lancet Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3109\/02656736.2014.995237","article-title":"International consensus on use of focused ultrasound for painful bone metastases: Current status and future directions","volume":"31","author":"Huisman","year":"2015","journal-title":"Int J Hyperther"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2003.10.006","article-title":"Single fraction radiotherapy is efficacious: a further analysis of the Dutch bone metastasis study controlling for the influence of retreatment","volume":"59","author":"van der Linden","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B7","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.ijrobp.2015.06.024","article-title":"Quality of life in relation to pain response to radiation therapy for painful bone metastases","volume":"93","author":"Westhoff","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B8","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3322\/caac.21242","article-title":"Palliative radiotherapy at the end of life: a critical review","volume":"64","author":"Jones","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"B9","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ijrobp.2011.10.080","article-title":"Effectiveness of reirradiation for painful bone metastases: a systematic review and meta-analysis","volume":"84","author":"Huisman","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dju082","article-title":"Magnetic resonance-guided focused ultrasound for patients with painful bone metastases: phase III trial results","volume":"106","author":"Hurwitz","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.16.01248","article-title":"Magnetic resonance-guided focused ultrasound versus conventional radiation therapy for painful bone metastasis: A matched-pair study","volume":"99","author":"Lee","year":"2017","journal-title":"J Bone Joint Surg Am"},{"key":"B12","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.prro.2016.08.001","article-title":"Palliative radiation therapy for bone metastases: Update of an ASTRO evidence-based guideline","volume":"7","author":"Lutz","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31280-1","article-title":"Statutory health insurance in Germany: a health system shaped by 135 years of solidarity, self-governance, and competition","volume":"390","author":"Busse","year":"2017","journal-title":"Lancet"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-016022","article-title":"Survival after bone metastasis by primary cancer type: a Danish population-based cohort study","volume":"7","author":"Svensson","year":"2017","journal-title":"BMJ Open"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s00066-002-0988-6","article-title":"Results of a nationwide survey on radiotherapy of bone metastases in Germany","volume":"178","author":"Adamietz","year":"2002","journal-title":"Strahlenther Onkol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0167-8140(00)00215-2","article-title":"Differences in palliative radiotherapy for bone metastases within Western European countries","volume":"56","author":"Lievens","year":"2000","journal-title":"Radiother Oncol"},{"key":"B17","unstructured":"OnkologieL\n          S3-leitlinie supportive therapie bei onkologischen PatientInnen: Deutsche krebsgesellschaft e.V2017"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2018.01.003","article-title":"Update of the systematic review of palliative radiation therapy fractionation for bone metastases","volume":"126","author":"Rich","year":"2018","journal-title":"Radiother Oncol"},{"key":"B19","doi-asserted-by":"crossref","DOI":"10.1016\/S0167-8140(99)00097-3","article-title":"The bone pain trial working party. 8 gy single fraction radiotherapy for the treatment of metastatic skeletal pain: randomised comparison with a multifraction schedule over 12 months of patient follow-up. bone pain trial working party","volume":"52","author":"Yarnold","year":"1999","journal-title":"Radiother Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2017.03.031","article-title":"Treatment and pattern of bone metastases in 1094 patients with advanced breast cancer - results from the prospective German tumour registry breast cancer cohort study","volume":"79","author":"Schr\u00f6der","year":"2017","journal-title":"Eur J Cancer"},{"key":"B21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s10198-012-0443-2","article-title":"Health state utilities for skeletal-related events secondary to bone metastases","volume":"15","author":"Matza","year":"2014","journal-title":"Eur J Health Econ"},{"key":"B22","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/1477-7525-9-96","article-title":"Deriving health state utilities for the numerical pain rating scale","volume":"9","author":"Dixon","year":"2011","journal-title":"Health Qual Life Outcomes"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-020-01247-z","article-title":"Healthcare resource utilization and associated cost of patients with bone metastases from solid tumors who are na\u00efve to bone-targeting agents: a comparative analysis of patients with and without skeletal-related events","volume":"22","author":"Hardtstock","year":"2021","journal-title":"Eur J Health econom: HEPAC: Health econom Prev Care"},{"key":"B24","unstructured":"Intitut fur entgeltsysteme im krankenhaus"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1080\/02656736.2021.2023768","article-title":"A time-driven activity-based costing approach of magnetic resonance-guided high-intensity focused ultrasound for cancer-induced bone pain","volume":"39","author":"Sim\u00f5es Corr\u00eaa Galendi","year":"2022","journal-title":"Int J hyperther"},{"key":"B26","unstructured":"Kassen\u00e4rztliche bundesvereinigung"},{"key":"B27","doi-asserted-by":"publisher","first-page":"691","DOI":"10.3111\/13696998.2013.779921","article-title":"Cost of skeletal-related events in European patients with solid tumours and bone metastases: data from a prospective multinational observational study","volume":"16","author":"Hechmati","year":"2013","journal-title":"J Med Econ"},{"key":"B28","unstructured":"Research institute of the AOK"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1017\/S0266462320001907","article-title":"Cost-effectiveness analysis of magnetic resonance-guided focused ultrasound ablation for palliation of refractory painful bone metastases","volume":"37","author":"Bucknor","year":"2020","journal-title":"Int J Technol Assess Health Care"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s00256-021-03822-8","article-title":"Efficacy and safety of magnetic resonance-guided focused ultrasound for the treatment of painful bone metastases: a systematic review and meta-analysis","volume":"50","author":"Baal","year":"2021","journal-title":"Skeletal Radiol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvir.2020.03.027","article-title":"Cost effectiveness of external beam radiation therapy versus percutaneous image-guided cryoablation for palliation of uncomplicated bone metastases","volume":"31","author":"Chang","year":"2020","journal-title":"J Vasc Interv Radiol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2019.03.021","article-title":"Adjusting for inflation and currency changes within health economic studies","volume":"22","author":"Turner","year":"2019","journal-title":"Value Health"},{"key":"B33","unstructured":"Institut f\u00fcr qualit\u00e4t und wirtschaftlichkeit im gesundheitswesen (IQWiG). methodik f\u00fcr die bewertung von verh\u00e4ltnissen zwischen nutzen und kosten im system der deutschen gesetzlichen krankenversicherung2008"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-015-0327-2","article-title":"AdViSHE: A validation-assessment tool of health-economic models for decision makers and model users","volume":"34","author":"Vemer","year":"2016","journal-title":"PharmacoEconomics"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2016.02.017","article-title":"Country-level cost-effectiveness thresholds: Initial estimates and the need for further research","volume":"19","author":"Woods","year":"2016","journal-title":"Value Health"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2020.01.001","article-title":"Value of information analysis for research decisions-an introduction: Report 1 of the ISPOR value of information analysis emerging good practices task force","volume":"23","author":"Fenwick","year":"2020","journal-title":"Value Health"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X13505910","article-title":"Estimating multiparameter partial expected value of perfect information from a probabilistic sensitivity analysis sample: a nonparametric regression approach","volume":"34","author":"Strong","year":"2014","journal-title":"Med decision making"},{"key":"B38","unstructured":"Centre for cancer registry data. cancer in Germany2018"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-017-0595-0","article-title":"Cost-effectiveness of treatments for the management of bone metastases: A systematic literature review","volume":"36","author":"Andronis","year":"2018","journal-title":"Pharmacoeconomics"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.15171\/ijhpm.2019.36","article-title":"Problems and promises of health technologies: The role of early health economic modeling","volume":"8","author":"Grutters","year":"2019","journal-title":"Int J Health Policy Manage"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.15171\/ijhpm.2019.119","article-title":"How useful are early economic models? comment on \u201cProblems and promises of health technologies: The role of early health economic modelling\u201d","volume":"9","author":"Love-Koh","year":"2020","journal-title":"Int J Health Policy Manage"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.617295","article-title":"The roles of magnetic resonance-guided focused ultrasound in pain relief in patients with bone metastases: A systemic review and meta-analysis","volume":"11","author":"Han","year":"2021","journal-title":"Front Oncol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40349-015-0033-8","article-title":"Effects of magnetic resonance-guided high-intensity focused ultrasound ablation on bone mechanical properties and modeling","volume":"3","author":"Yeo","year":"2015","journal-title":"J Ther Ultrasound"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.clon.2009.08.004","article-title":"International variations in radiotherapy fractionation for bone metastases: geographic borders define practice patterns","volume":"21","author":"van der Linden","year":"2009","journal-title":"Clin Oncol (Royal Coll Radiol (Great Britain))"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2021.01.003","article-title":"Hypofractionated radiotherapy in the real-world setting: An international ESTRO-GIRO survey","volume":"157","author":"Rodin","year":"2021","journal-title":"Radiother Oncol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/s0167-8140(00)00214-0","article-title":"Palliative radiotherapy practice within Western European countries: impact of the radiotherapy financing system","volume":"56","author":"Lievens","year":"2000","journal-title":"Radiother Oncol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2014.01.015","article-title":"Review of international patterns of practice for the treatment of painful bone metastases with palliative radiotherapy from 1993 to 2013","volume":"111","author":"Popovic","year":"2014","journal-title":"Radiother Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.987546\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T01:19:34Z","timestamp":1663895974000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.987546\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,23]]},"references-count":47,"alternative-id":["10.3389\/fonc.2022.987546"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.987546","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,23]]},"article-number":"987546"}}